Pascal Collin

Title: Innovations in Cancer Treatment by Pascal Collin

Introduction

Pascal Collin is a notable inventor based in Buc, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer and diseases related to excessive angiogenesis. With a total of 2 patents, his work is paving the way for new therapeutic approaches.

Latest Patents

Collin's latest patents include the use of a novel 3-aryl-4-catechol-pyrrole-N-propanol compound and its derivatives to treat cancer. This invention focuses on a compound with a general formula that includes an aryl group, which can be substituted by various functional groups. The invention also details methods for preparing the compound and its use as a drug or prodrug in cancer treatment. Another significant patent involves N-substituted 3,4-bis(catechol) pyrrole compounds, which are designed for the same therapeutic purpose. This compound features a complex formula that allows for various substitutions, enhancing its potential efficacy in treating cancer.

Career Highlights

Pascal Collin is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work there has allowed him to focus on innovative research that addresses critical health challenges.

Collaborations

Collin has collaborated with notable colleagues such as Bernard Delpech and Joanna Bakala. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Pascal Collin's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the pharmaceutical field. His patents represent significant advancements that could lead to improved therapies for patients.